|
Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial |
|
|
|
Titel: |
Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial |
Auteur: |
Argente, Jesús Verge, Charles F Okorie, Uzoma Fennoy, Ilene Kelsey, Megan M Cokkinias, Casey Scimia, Cecilia Lee, Hak-Myung Farooqi, I Sadaf |
Verschenen in: |
The lancet diabetes & endocrinology |
Paginering: |
Jaargang 13 () nr. 1 pagina's 29-37 |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|